A Multicenter Study to Evaluate Subject Satisfaction With Two Treatments of AbobotulinumtoxinA a Year in the Glabellar Lines

por Schlessinger, Joel, Cohen, Joel L., Shamban, Ava, Jacob, Carolyn, Karimi, Kian, Maas, Corey, Lane, Vanessa, Coquis-Knezek, Sarah, Meckfessel, Matthew
Publicado 2021

Safety, Pharmacodynamic Response, and Treatment Satisfaction With OnabotulinumtoxinA 40 U, 60 U, and 80 U in Subjects With Moderate to Severe Dynamic Glabellar Lines

por Joseph, John H, Maas, Corey, Palm, Melanie D, Lain, Edward, Glaser, Dee Anna, Bruce, Suzanne, Yoelin, Steven, Cox, Sue Ellen, Fagien, Steven, Sangha, Sara, Maltman, John, Lei, Xiaofang, Brin, Mitchell F
Publicado 2022

Corrigendum to: The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lin...

por Kaufman-Janette, Joely, Avelar, Rui L, Biesman, Brian S, Draelos, Zoe Diana, Gross, John E, Jones, Derek H, Lupo, Mary P, Maas, Corey S, Schlessinger, Joel, Shamban, Ava Teresa, Sundaram, Hema, Weinkle, Susan H, Young, Vernon L
Publicado 2021

The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Pati...

por Kaufman-Janette, Joely, Avelar, Rui L, Biesman, Brian S, Draelos, Zoe Diana, Gross, John E, Jones, Derek H, Lupo, Mary P, Maas, Corey S, Schlessinger, Joel, Shamban, Ava Teresa, Sundaram, Hema, Weinkle, Susan H, Young, Vernon L
Publicado 2021